Belgium· BE-AMP-SAM316967-00
Lansoprazole EG 30 mg
A lansoprazole product containing lansoprazole, registered in Belgium by PI Pharma. The same ATC class is registered in 19 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lansoprazole is registered in 19 of 19 countries.
Countries holding a registration under ATC A02BC03 (lansoprazole), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Lansoprazole · ATC A02BC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lansoprazole costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in France to $0.75 in Switzerland — a ×5.2 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lansoprazole · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.75
- ES Spain$0.32
- IT Italy$0.22
- FR France$0.15
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lansoprazole
- Manufacturer
- PI Pharma
- Country
- Belgium (BE)
- ATC code
- A02BC03
- ATC class
- Lansoprazole
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2727410
- be_apb0798363
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
743 interactions on record for lansoprazole.
Graded by severity as the source publishes them — 24 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lansoprazole · interactions on record
743 records
- 24 severe
- 125 moderate
- 34 minor
- 550 info
Most severe, free to view
- CilostazolB01AC23severe
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A02BC03
Lansoprazole, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5255056-bf1a-4be9-baf9-7020fc3f66de GET /v1/drugs/e5255056-bf1a-4be9-baf9-7020fc3f66de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gastro-resistant capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Lansoprazole EG 30 mg",
"name_fr": "Lansoprazole EG 30 mg",
"name_nl": "Lansoprazole EG 30 mg",
"amp_code": "SAM316967-00",
"strengths": [
"30.0000"
],
"pack_count": 4,
"substances": [
"Lansoprazole"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Lansoprazole",
"authorisation_numbers": [
"1637PI0035F004"
]
}See everything about lansoprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.